DIC (TSE:4631) has quietly outperformed the broader Japanese market this year, and that steady climb has investors asking whether this specialty chemicals name still offers value after a strong run.

DIC related to cancer is always secondary to a well-defined clinical condition. (See Table 1 for a list of common causes of DIC related to cancer.) This point is important to remember, as treatment of ...

If you are wondering whether DIC is still good value after its recent run, you are not alone. This is exactly the kind of stock where the headline share price does not tell the full story. The share ...

This page lists all known medications that could potentially lead to 'Disseminated intravascular coagulation' as a side effect. It's important to note that mild side effects are quite common with ...

Since it was described a half-century ago, the concept of disseminated intravascular coagulation (DIC) and its underlying pathogenesis have taken shape in accordance with the understanding of the ...

Newly returned to Los Angeles from a development position in France with DIC Audiovisual, Andy Heyward promptly took control of the company from Radio-Television Luxembourg, rebranding it DIC ...

The syndrome of disseminated intravascular coagulation (DIC) is a serious hypercoagulation state that occurs in a variety of disease states, including cancer. Although DIC is often associated with ...